Re-Evaluating PIN1 as a Therapeutic Target in Oncology Using Neutral Inhibitors and PROTACs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Re-Evaluating PIN1 as a Therapeutic Target in Oncology Using Neutral Inhibitors and PROTACs

Published:2024-09-04 Issue:17 Volume:67 Page:15780-15795
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Liu Chuan¹,Chen Zhonghui²,Chen Tao¹,Song Hongmei²,Shen Jianbo¹,Yuan Xiaoxi²,Xia Shuai¹,Liu Qian²,Chen Qiuxia¹,Tian Qiang²,Meng Xiaoyun¹,Han Zhu²,Dong Xiaofei¹,Yang Yu²,Cai Longying¹,Cheng Xuemin¹,Jia Yangyang²,Liu Guansai¹^ORCID,Li Jin¹,Ge Junyou²,Dou Dengfeng¹^ORCID

Affiliation:

1. HitGen Inc., Shuangliu District, Chengdu, Sichuan 610200, P. R. China

2. Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd., Wenjiang District, Chengdu, Sichuan 611138, P. R. China

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.4c01412

Reference39 articles.

1. A human peptidyl–prolyl isomerase essential for regulation of mitosis

2. Prolyl isomerase Pin1 promotes autophagy and cancer cell viability through activating FoxO3 signalling

3. Structural and Functional Analysis of the Mitotic Rotamase Pin1 Suggests Substrate Recognition Is Phosphorylation Dependent

4. Pin1 as an anticancer drug target

5. A Guide to PIN1 Function and Mutations Across Cancers

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP